Some call it Tamiflu, others call it oseltamivir. It's a useful medicine in the treatment of influenza. But, like many modern drugs, its main faults lie in finding the individual components for its creation, and the waste produced in their creation - both of which add to the drug's final price.
So, what if you could chop the production process of the drug in half; saving time, energy, cost, and potentially large amounts of medicinal waste? That's exactly what the team under Professor Radovan Šebesta have achieved at Comenius University in Bratislava. Not only that, they're confident enough in their discovery that they've even filed to have their process patented, as Gavin Shoebridge discovered.
Cheaper cleaner oseltamivir
Máte problém s prehrávaním? Nahláste nám chybu v prehrávači.
